Breaking News

You are here » Indian-Commodity  :  Top News  :  Sun Pharma receives Australian TGA approval for ILUMYA

21-Sep2018

Sun Pharma receives Australian TGA approval for ILUMYA

Sun Pharmaceutical Industries has received the Australian Therapeutic Goods Administration (TGA) approval for its specialty product, ILUMYA (tildrakizumab) for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.

ILUMYA selectively binds to the p19 subunit of IL-23 and inhibits its interaction with the IL23 receptor leading to inhibition of the release of proinflammatory cytokines and chemokines. ILUMYA is administered at a dose of 100 mg by subcutaneous injection every 12 weeks after the completion of initial doses at weeks 0 and 4. ILUMYA is contraindicated in patients with a previous serious hypersensitivity reaction to tildrakizumab or to any of the excipients in ILUMYA, and in patients with clinically important active infections, e.g. active tuberculosis.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.


Related News

View all news

Crude oil futures end higher on Tuesday

After falling in previous session, Crude oil futures ended higher on Tuesday in the wake of a short-term disruption in Libyan output. Libya's national oil company has declared force majeure on exports......

Gold futures end lower on strong dollar

Gold futures ended lower on Monday as the strong dollar against some major basket of currencies after the British Prime Minister Theresa May postponed Parliament's vote on Brexit deal with the European......

Physical Rubber prices witness improvement on Monday

Physical Rubber prices showed improvement on Monday due to bargain buying by markets participants after a recent fall in prices. However, fall in benchmark contracts of the Tokyo Commodity Exchange capped......

Top News

View all news

Wipro, Palred Technologies and Zydus Wellness to see some action today

Wipro has launched an Automotive Innovation Center in Detroit, Michigan. This state-of-the-art technology hub will deepen Wipro's relationship with Detroit's automotive community, develop and showcase......

Wipro launches Automotive Innovation Center in Detroit

Wipro has launched an Automotive Innovation Center in Detroit, Michigan. This state-of-the-art technology hub will deepen Wipro's relationship with Detroit's automotive community, develop and showcase......

Zydus Wellness gets CCI's approval for acquisition of Heinz

Zydus Wellness (ZWL) has received approval from the Competition Commission of India (CCI) for the company's acquisition of Heinz India jointly with Cadila Healthcare. The definitive agreement in relation......